Omidenepag and its Impurities

Omidenepag, is a novel selective, non-prostanoid EP2 receptor agonist for the treatment of Glaucoma: Reference standards of Omidenepag API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.